The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| XXII | -99.65% | -100% | -92.65% | -100% |
| S&P | +13.96% | +91.24% | +13.85% | +427% |
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
All three are pursuing strategies that are working and will work even better in the long term.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $4.01M | -32.5% |
| Gross Profit | -$1.17M | -69.0% |
| Gross Margin | -29.12% | -17.5% |
| Market Cap | $6.39M | 1.1% |
| Market Cap / Employee | $0.11M | 0.0% |
| Employees | 56 | -12.5% |
| Net Income | -$3.76M | -5.0% |
| EBITDA | -$2.80M | 8.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.85M | -9.3% |
| Accounts Receivable | $2.99M | 67.8% |
| Inventory | 2.9 | 24.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.38M | -52.0% |
| Short Term Debt | $0.53M | -77.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -49.81% | 23.9% |
| Return On Invested Capital | -867.93% | -20.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4.02M | -32.1% |
| Operating Free Cash Flow | -$4.02M | -35.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.97 | 1.09 | 0.25 | 0.14 | -92.43% |
| Price to Sales | 0.09 | 0.10 | 0.09 | 1.11 | 960.71% |
| Price to Tangible Book Value | -521.13 | 49.35 | -3.12 | 0.55 | -100.04% |
| Enterprise Value to EBITDA | -1.60 | -3.04 | -1.58 | -6.85 | 224.80% |
| Return on Equity | -286.0% | -385.9% | -616.1% | -133.5% | -61.46% |
| Total Debt | $8.62M | $5.56M | $5.43M | $3.91M | -58.22% |
No podcast episodes available.
XXII earnings call for the period ending June 30, 2023.
XXII earnings call for the period ending March 31, 2023.
XXII earnings call for the period ending December 31, 2022.
XXII earnings call for the period ending September 30, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
